Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 667463-62-9 Chemical Structure| 667463-62-9

Structure of GSK 3 Inhibitor IX
CAS No.: 667463-62-9

Chemical Structure| 667463-62-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

BIO is an inhibitor of GSK-3 and CDK1–cyclinB complex. The IC50s of GSK-3αβ, CDK1, CDK5 are 5 nM, 320 nM and 83 nM, respectively.

Synonyms: 6-Bromoindirubin-3'-oxime; MLS 2052; 6-bromoindirubin-3-oxime

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of GSK 3 Inhibitor IX

CAS No. :667463-62-9
Formula : C16H10BrN3O2
M.W : 356.17
SMILES Code : O=C1NC2=C(C=CC(Br)=C2)/C1=C3NC4=C(C=CC=C4)C/3=N\O
Synonyms :
6-Bromoindirubin-3'-oxime; MLS 2052; 6-bromoindirubin-3-oxime
MDL No. :MFCD08705318
InChI Key :SAQUSDSPQYQNBG-UHFFFAOYSA-N
Pubchem ID :448949

Safety of GSK 3 Inhibitor IX

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H228-H315-H319
Precautionary Statements:P240-P210-P241-P264-P280-P302+P352-P370+P378-P337+P313-P305+P351+P338-P362+P364-P332+P313
Class:4.1
UN#:1325
Packing Group:

Related Pathways of GSK 3 Inhibitor IX

PI3K-AKT
Hedgehog

Isoform Comparison

Biological Activity

Target
  • GSK-3

    GSK-3, IC50:5 nM

In Vitro:

Cell Line
Concentration Treated Time Description References
Huh-7 cells 2 μM 24 hours GSK 3 Inhibitor IX significantly reduced PA-mediated lipoapoptosis and decreased caspase 3/7 activity. PMC3060963
Hep3B cells 2 μM 16 hours GSK 3 Inhibitor IX significantly reduced PA-mediated lipoapoptosis and decreased caspase 3/7 activity. PMC3060963
Mouse primary hepatocytes 2 μM 16 hours GSK 3 Inhibitor IX significantly reduced PA-mediated lipoapoptosis and decreased caspase 3/7 activity. PMC3060963

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Tail suspension test (TST) Intracerebroventricular injection 50 mg/kg Twice daily for 28 days To verify whether the combined use of AR-A014418 and guanosine would produce an antidepressant-like effect. The results showed that the co-administration of AR-A014418 and guanosine significantly reduced the immobility time of mice in the TST, indicating a synergistic antidepressant effect. PMC6923309
Mice Tail suspension test (TST) Intracerebroventricular injection 25 nmol 3 times a week for 10 weeks To investigate the role of GSK-3 β inhibition in the antidepressant-like effect of guanosine, results showed that the co-administration of guanosine and AR-A014418 produced a synergistic antidepressant-like effect in the TST. PMC6923309

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.81mL

0.56mL

0.28mL

14.04mL

2.81mL

1.40mL

28.08mL

5.62mL

2.81mL

References

 

Historical Records

Categories